Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Elevated CXCL13 in primary Sjögren’s syndrome and its correlation with disease activity: a systematic review and meta-analysis
Tong Zhu, Zijian Pan, Nannan Zhang
Clinical Rheumatology (2022) Vol. 41, Iss. 9, pp. 2791-2802
Closed Access | Times Cited: 13

Showing 13 citing articles:

Saliva biomarkers in oral disease
Yuehong Zhou, Zhenqi Liu
Clinica Chimica Acta (2023) Vol. 548, pp. 117503-117503
Closed Access | Times Cited: 28
Chemokines and lymphocyte homing in Sjögren’s syndrome
Jiahe Liao, Xinbo Yu, Ziwei Huang, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 9
CXCL9 may serve as a potential biomarker for primary Sjögren’s syndrome with extra-glandular manifestations
Jingwei Hong, Hui Cheng, Ping Wang, et al.
Arthritis Research & Therapy (2024) Vol. 26, Iss. 1
Open Access | Times Cited: 4
The role of epithelial cells in the immunopathogenesis of Sjögren's syndrome
Yuan Yan Tang, Yingbo Zhou, Xiaoran Wang, et al.
Journal of Leukocyte Biology (2023) Vol. 115, Iss. 1, pp. 57-67
Closed Access | Times Cited: 10
Expression of interleukin-18 in primary Sjögren syndrome and its potential mechanisms with disease: A systematic review and meta-analysis
Ying Deng, Yi-Feng Wang, Cheng Yi-juan, et al.
Medicine (2025) Vol. 104, Iss. 12, pp. e41919-e41919
Open Access
LTK deficiency induces macrophage M2 polarization and ameliorates Sjogren's syndrome by reducing chemokine CXCL13
Xiuyuan Feng, Junhui Lu, Cheng Wei, et al.
Cytokine (2025) Vol. 190, pp. 156905-156905
Closed Access
Salivary gland biopsy as a prognostic tool in Sjögren’s syndrome
Roberto Dal Pozzolo, Giacomo Cafaro, Carlo Perricone, et al.
Expert Review of Clinical Immunology (2024), pp. 1-9
Closed Access | Times Cited: 3
A Practical Multidisciplinary Approach to Identifying Interstitial Lung Disease in Systemic Autoimmune Rheumatic Diseases: A Clinician’s Narrative Review
Viorel Biciușcă, Anca Roşu, Sorina Ionelia Stan, et al.
Diagnostics (2024) Vol. 14, Iss. 23, pp. 2674-2674
Open Access | Times Cited: 3
The MIDORA trial: a phase II, randomised, double-blind, placebo-controlled, mechanistic insight and dosage optimisation study of the efficacy and safety of dazodalibep in patients with rheumatoid arthritis
Alan Kivitz, Handong Wang, Ilias Alevizos, et al.
RMD Open (2023) Vol. 9, Iss. 3, pp. e003317-e003317
Open Access | Times Cited: 8
CXCL13: a common target for immune-mediated inflammatory diseases
Hui Lü, Ye Li, Meng-ke Huang, et al.
Clinical and Experimental Medicine (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 1
Diagnostic role of CXCL13 biomarker in primary Sjogren's syndrome patients with parotid non-Hodgkin's lymphoma complication
Maria Bădărînză, Oana Șerban, Lavinia Maghear, et al.
Medicina Clínica (2023) Vol. 160, Iss. 11, pp. 484-488
Closed Access | Times Cited: 1
Identification of circRNAs expression profiles and functional networks in parotid gland of type 2 diabetes mouse
Yan Huang, Huimin Liu, Qian‐Ying Mao, et al.
BMC Genomics (2024) Vol. 25, Iss. 1
Open Access
Diagnostic role of CXCL13 biomarker in primary Sjogren's syndrome patients with parotid non-Hodgkin's lymphoma complication
Maria Bădărînză, Oana Șerban, Lavinia Maghear, et al.
Medicina Clínica (English Edition) (2023) Vol. 160, Iss. 11, pp. 484-488
Closed Access
Page 1

Scroll to top